TONELLA, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 575
EU - Europa 234
AS - Asia 69
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
Totale 891
Nazione #
US - Stati Uniti d'America 574
IT - Italia 109
IE - Irlanda 57
CN - Cina 37
SE - Svezia 36
IN - India 11
SG - Singapore 7
DE - Germania 6
FR - Francia 6
KR - Corea 6
NG - Nigeria 6
BE - Belgio 5
UA - Ucraina 5
EU - Europa 4
HK - Hong Kong 4
ES - Italia 3
DK - Danimarca 2
RO - Romania 2
BR - Brasile 1
CA - Canada 1
CL - Cile 1
GB - Regno Unito 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
PH - Filippine 1
RU - Federazione Russa 1
UG - Uganda 1
VN - Vietnam 1
Totale 891
Città #
Chandler 209
Dublin 57
Ashburn 32
Nyköping 30
Princeton 19
Milan 16
Boston 15
Medford 14
Hebei 12
Beijing 10
Pune 9
Hangzhou 8
Turin 8
Norwalk 7
Abuja 6
New York 6
Rome 6
Seoul 6
Singapore 6
Ann Arbor 5
Bologna 5
Brussels 5
Cambridge 5
Washington 5
Wilmington 5
Cinisello Balsamo 4
Cittiglio 4
Redmond 4
Jacksonville 3
Los Angeles 3
Porto Empedocle 3
Torino 3
Almodóvar Del Campo 2
Arcole 2
Brescia 2
Cesena 2
Chengdu 2
Dreieich 2
Guiyang 2
Hong Kong 2
Istrana 2
L’Aquila 2
Muggiò 2
Paris 2
Redwood City 2
Salerno 2
San Diego 2
San Jose 2
Seattle 2
Terracina 2
Udine 2
West Jordan 2
Zhengzhou 2
Bari 1
Belluno 1
Buguggiate 1
Castelfiorentino 1
Central District 1
Centro 1
Dong Ket 1
Eitensheim 1
Fairfield 1
Falls Church 1
Florence 1
Frankfurt am Main 1
Hyderabad 1
Kolkata 1
Madrid 1
Marcianise 1
Marigliano 1
Molfetta 1
Mountain View 1
Petrolina 1
Piraeus 1
Recanati 1
San Mateo 1
Santiago 1
Suceava 1
Tehran 1
Terni 1
Toronto 1
Upper Marlboro 1
Vidin 1
Woodbridge 1
Totale 603
Nome #
Alopecia areata after COVID-19 vaccination 112
CD38 Expression by Circulating and Skin-Infiltrating Lymphocytes from Sezary Syndrome Patients: A Flow Cytometry and Immunohistochemistry Study 64
Effectiveness and Safety of Dupilumab for the Treatment of Atopic Dermatitis in Adult Cohort: a Real-Life Italian Tertiary Centre Experience 56
Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: Experience from an Italian skin cancer unit 54
Acute appendicitis secondary to desmoplastic melanoma metastasis in immune-checkpoint inhibitors era 53
Treatment of early-phase mycosis fungoides: results from the Prospective Cutaneous Lymphoma International (PROCLIPI) study 52
Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study 52
Clinical significance of distant metastasis-free survival (Dmfs) in melanoma: A narrative review from adjuvant clinical trials 51
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome 49
Infections in Sézary syndrome: A retrospective cohort study of 113 patients 47
Nutritional interventions for patients with melanoma: From prevention to therapy—an update 46
Prognostic and predictive biomarkers in stage iii melanoma: Current insights and clinical implications 44
Metastatic melanoma treatment with checkpoint inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit 42
Differences in cutaneous melanoma survival between the 7th and 8th edition of the American Joint Committee on Cancer (AJCC). A multicentric population-based study 40
Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives 34
Evolution of different clinical patterns of cutaneous lesions in a suspected COVID-19 patient 31
Predictive value of baseline [18f]fdg pet/ct for response to systemic therapy in patients with advanced melanoma 30
Treatment of Advanced Metastatic Melanoma 29
Clinical evaluation of hydration index using a corneometer in metastatic melanoma patients treated with BRAF/MEK inhibitors: a prospective study 24
Emerging prognostic biomarkers in advanced cutaneous melanoma: a literature update 8
Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancer 4
Exploring the role of epigenetic alterations and non-coding RNAs in melanoma pathogenesis and therapeutic strategies 2
Totale 924
Categoria #
all - tutte 4.261
article - articoli 0
book - libri 0
conference - conferenze 237
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.498


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013 0 0 0 0 0 0 2 0 1 0 3 7
2020/202124 2 0 3 1 0 2 1 3 5 1 3 3
2021/2022230 17 0 9 3 37 10 13 8 4 6 47 76
2022/2023485 39 57 13 52 39 97 27 42 61 15 24 19
2023/2024172 23 29 10 13 12 39 0 5 0 18 15 8
Totale 924